Back
Compare AU
Compare VDAL vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Diversified All Growth Index ETF (VDAL) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VDAL | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 203 | 365 |
Median incremental investment | $1,174.50 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,390.00 | $1,890.70 |
Average age group | > 35 | 26 - 35 |
Key Summary
VDAL | IXJ | |
|---|---|---|
Strategy | VDAL.AX was created on 2025-03-04 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified All Growth Index ETF seeks to track the weighted average return of the various indices of the Underlying Funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. IXJ.AX tracks a market-cap-weighted index of global health care companies. |
Top 3 holdings | Vanguard Australian Shares ETF (36.20 %) Vanguard MSCI Intl ETF (27.20 %) Vanguard MSCI Intl (Hdg) ETF (16.40 %) | ISHARES GLOBAL HEALTHCARE ETF TRUS (99.97 %) USD CASH (0.10 %) USD/AUD (0.00 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | |
Top 3 countries | United States (40.42 %) Australia (38.39 %) Japan (3.50 %) | United States (71.77 %) Switzerland (9.51 %) United Kingdom of Great Britain and Northern Ireland (5.59 %) |
Management fee | 0.27 % | 0.46 % |
Key Summary
VDAL | IXJ | |
|---|---|---|
Issuer | Vanguard | iShares |
Tracking index | 40% S&P/ASX 300 Index - 29.5% MSCI World ex-Australia Index - 18% MSCI World ex-Australia Index - 7% MSCI World ex-Australia Small Cap Index - 5.5% MSCI Emerging Markets Index - Benchmark TR Net | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.27 % | 0.46 % |
Price | $56.50 | $135.05 |
Size | N/A | $1.308 billion |
10Y return | N/A | 96.12 % |
Annual distribution yield (5Y) | 1.79 % | 1.26 % |
Market | ASX | ASX |
First listed date | 04/03/2025 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VDAL | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 203 | 365 |
Median incremental investment | $1,174.50 | $993.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,390.00 | $1,890.70 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
VDAL | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VDAL | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |